miR-Test: A Blood Test for Lung Cancer Early Detection

Concerns remain about the definition of a high risk population who can benefit from low-dose computed tomography screening programs. In this paper, the authors present a promising tool to optimize lung cancer screening in a high-risk population using a serum microRNA signature (miR-Test).  The area under the ROC curve  of test is 0.85 (95% CI = 0.78 to 0.92).